Literature DB >> 11821019

Potent desensitization of human P2X3 receptors by diadenosine polyphosphates.

Heath A McDonald1, Katharine L Chu, Bruce R Bianchi, David G McKenna, Clark A Briggs, Edward C Burgard, Kevin J Lynch, Connie Faltynek, Jayne Cartmell, Michael F Jarvis.   

Abstract

In this study, the receptor desensitizing effects of diadenosine polyphosphates at recombinant human P2X3 (hP2X3) receptors were examined. Administration of Ap3A, Ap4A, Ap5A or Ap6A inhibited the hP2X3 receptor-mediated response to a subsequent application of 3 muM alphabeta-methyleneATP (alphabeta-meATP), in a concentration-dependent manner, with IC50 values 2707, 42, 59 and 46 nM, respectively. These agonists did not desensitize alphabeta-meATP responses mediated by the slowly desensitizing heteromeric human P2X2/3 receptor. hP2X3 receptor desensitization was reversible and was not observed following the increase in intracellular Ca2+ levels produced by carbachol. A similar pattern of desensitization evoked by Ap5A was also observed using electrophysiological recordings of Xenopus oocytes expressing hP2X3 receptors. These data demonstrate that diadenosine polyphosphates, found endogenously in the central nervous system, can readily desensitize hP2X3 receptors at nanomolar concentrations that are 10-fold lower than are required to produce agonist-induced receptor activation. Thus, P2X3 receptor desensitization by diadenosine polyphosphates may provide an important modulatory mechanism of P2X3 receptor activation in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821019     DOI: 10.1016/s0014-2999(01)01568-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Diadenosine tetra- and pentaphosphates affect contractility and bioelectrical activity in the rat heart via P2 purinergic receptors.

Authors:  Ksenia B Pustovit; Vladislav S Kuzmin; Denis V Abramochkin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-17       Impact factor: 3.000

2.  Agonist-dependence of recovery from desensitization of P2X(3) receptors provides a novel and sensitive approach for their rapid up or downregulation.

Authors:  Elena Sokolova; Andrei Skorinkin; Elsa Fabbretti; Lara Masten; Andrea Nistri; Rashid Giniatullin
Journal:  Br J Pharmacol       Date:  2004-02-23       Impact factor: 8.739

3.  Tonic Calcium-Activated Chloride Current Sustained by ATP Release and Highly Desensitizing Human P2X1 Receptors.

Authors:  Agenor Limon; Garo Hagopian; Jorge M Reyes-Ruiz; Ricardo Miledi
Journal:  Neuroscience       Date:  2019-07-23       Impact factor: 3.590

Review 4.  Desensitization properties of P2X3 receptors shaping pain signaling.

Authors:  Rashid Giniatullin; Andrea Nistri
Journal:  Front Cell Neurosci       Date:  2013-12-06       Impact factor: 5.505

5.  Stable, synthetic analogs of diadenosine tetraphosphate inhibit rat and human P2X3 receptors and inflammatory pain.

Authors:  Viacheslav Viatchenko-Karpinski; Natalia Novosolova; Yevheniia Ishchenko; M Ameruddin Azhar; Michael Wright; Vera Tsintsadze; Ahmed Kamal; Nail Burnashev; Andrew D Miller; Nana Voitenko; Rashid Giniatullin; Natalia Lozovaya
Journal:  Mol Pain       Date:  2016-03-29       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.